Long-term persistent immunogenicity after successful standard and triple-dosed hepatitis B vaccine in hemodialysis patients: A 3-year follow-up study in China.
Yao T, Shao Z, Wu L, Dong S, Gao L, Wu Y, Shi X, Shi J, Liu G, Wang J, Zhao H, Guo H, Liu H, Wu X, Liu L, Song X, Zhu J, Zhang Y, Feng Y, Liang X, Wang S.
Yao T, et al.
Vaccine. 2021 Apr 28;39(18):2537-2544. doi: 10.1016/j.vaccine.2021.03.074. Epub 2021 Apr 2.
Vaccine. 2021.
PMID: 33814231
Clinical Trial.
We explored the long-term persistence of immunogenicity induced by different hepatitis B vaccine regimens in hemodialysis patients. ...Peak anti-HBs level after vaccination was associated with the long-term persistence of immunogenicity....
We explored the long-term persistence of immunogenicity induced by different hepatitis B vaccine regimens in hemodialysis patients. . …